BioBlogger is a new contributor to Seeking Alpha who will soon submit a bio.
Note: Seeking Alpha editors have contact information for all contributors, to enable ongoing communication regarding articles published.
BioBlogger's Latest Articles
Page 1 of 2
-
Encysive Pharmaceuticals Blind-Sided: Thelin Receives Approvable Letter from FDA
on Mar 28, 2006
about
ENCY
-
FDA Delay of Tysabri Verdict Not a Surprise (BIIB, ELN)
-
Nabi Biopharmaceuticals Continues Clinical Development of StaphVax (NABI)
on Mar 24, 2006
about
NABI
-
Tysabri Comes Out On Top At FDA Panel Meeting (BIIB, ELN)
-
Tysabri To Be Discussed At FDA Advisory Committee Meeting: Findings From The Briefing Documents (BIIB, ELN)
-
Research Report Highlights Reality of Tysabri’s Prospects (ELN, BIIB)
-
FDA Has Egg On Its Face…Again (NFLD)
on Feb 23, 2006
about
NFLD
-
Does Adolor’s Announcement of Positive Entereg Data Assure FDA Approval? (ADLR)
on Feb 08, 2006
about
ADLR
-
Barron’s Tepid Review of Amylin Pharmaceuticals (AMLN, PFE, NKTR, SNY, NVO)
-
Gilead Reports Another Solid Quarter (GILD, BMY)
-
Upheaval at Imclone (IMCL, BMY, AMGN, ABGX)
-
Fate of Serono: J&J Hires Citigroup to Examine a Formal Bid (SRA, JNJ, GDT, STJ, ELN, BIIB)
-
Biotech Stocks Q4 2005 Earnings Scorecard
-
It’s Official: FDA Panel Will Review Tysabri On March 7th (ELN, BIIB)
-
BioCryst Receives Fast-Track Status for Peramivir, But Does It Justify The Stock's Appreciation? (BCRX)
on Jan 18, 2006
about
BCRX
-
Should Pfizer Acquire Kos Pharmaceuticals? (PFE, KOSP, MRK)
-
Nitromed Update: Cramer Re-Visited (NTMD)
on Jan 05, 2006
about
NTMD
-
Amgen Makes Bid To Acquire Abgenix For $2.2 billion (AMGN, ABGX)
-
PAH Market Heats Up: Myogen Reports Positive Data of Ambrisentan (MYOG)
-
Tysabri Panel Meeting in March? (BIIB, ELN)
-
Bait And Switch: American Pharmaceutical Partners’ Proposed Acquisition of American BioScience (APPX)
on Nov 30, 2005
about
APPX
-
Diabetes Market Heating Up: Novo Nordisk Releases Positive Liraglutide Data (AMLN, NVO)
-
Report of Pediatric Deaths In Japan Linked To Tamiflu Are Overblown (RHHBY, GILD)
-
Celgene Goes 0-for-4 With Thalomid (CELG)
on Nov 16, 2005
about
CELG
-
Rumor Du Jour: Wyeth Looking at Acquiring Elan (WYE, ELN)
on Nov 16, 2005
about
ELN,
WYE
-
MGI Pharma and Supergen Respond to FDA Approvable Letter and Pull MAA in Europe (MOGN, SUPG, PHRM)
-
The Hidden M.O. Behind Jim Cramer's "Bullish" Call on Nitromed (NTMD)
on Nov 09, 2005
about
NTMD
-
Nexavar (aka, Sorafenib) Phase 3 Data Released at ECCO (ONXX, BAY, PFE)
-
Panitumumab Data and the Implications for Erbitux (ABGX, AMGN, IMCL)
-
The President's Avian Flu Plan: Boon or Bust for the Speculators? (BCRX, GILD, QDEL, RHHBY)
-
Medimmune Q3 Earnings Overview (MEDI)
-
Imclone Q3 Earnings Overview (IMCL)
